Eli Lilly

2. Eli Lilly

Total Ad Spend: $433.4 million
Television: $367.3 million
Magazine: $43.4 million
Other: $22.7 million

Eli Lilly ($LLY) is getting what it can from erectile dysfunction (ED) drug Cialis and antidepressant Cymbalta while the gettin' is good. It loses patent protection late this year on Cymbalta, which has been generating about $5 billion annually. Lilly also keeps pushing Cialis. A recent study criticized the industry for failing to adhere to voluntary guidelines on when such ads will run, pointing out that ads for Cialis and other ED drugs have crept into family viewing time slots. 

In the spotlight

Cymbalta for pain, $165.8 million
Cialis, $162.8 million
Cymbalta for depression, $77.2 million


Eli Lilly

Suggested Articles

FDA officials say Novartis took too long to launch a formal probe into allegations of Zolgensma data manipulation.

Should Johnson & Johnson owe billions to fix Oklahoma's opioid crisis? After weeks of trial testimony, a judge will have his say Monday afternoon.

After Endo and Allergan agreed to settle with two Ohio counties on opioid charges this week, the state’s AG has a message: You’re not off the hook.